Currently, there are clinical studies using AAV vectors to transfect sarcoplasmic/endoplasmic reticulum Ca (2+)-ATPase (SERCA2a) to treat heart failure [255, 256]
doi: 10.1016/j.drudis.2006.10.013 46
[5] The primary contraindication for hydroxocobalamin injection is a known hypersensitivity to hydroxocobalamin, cobalt, or any component of the formulation
For instance, building upon the established role of GPX4 in suppressing ferroptosis in alveolar cells, the demonstrated therapeutic potential of mesenchymal stem cell-derived exosomes, the feasibility of CD44-mediated macrophage targeting, and the precedent for pulmonary nucleic acid delivery, the engineering of inhaled exosomes to deliver GPX4 mRNA specifically to alveolar macrophages represents a promising frontier (175, 178)
In laboratory studies, synthetic BPC-157 is reported to: Support the healing of wounds, and certain injuries Promote recovery after tissue traumas Limit the impact of systemic insults including hyperkalemia and hypermagnesia Promisingly, few studies are reporting any adverse reactions to the administration of BPC 157